These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 15308178)
1. Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex. Kulvik ME; Vähätalo JK; Benczik J; Snellman M; Laakso J; Hermans R; Järviluoma E; Rasilainen M; Färkkilä M; Kallio ME Appl Radiat Isot; 2004 Nov; 61(5):975-9. PubMed ID: 15308178 [TBL] [Abstract][Full Text] [Related]
2. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy. Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436 [TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940 [TBL] [Abstract][Full Text] [Related]
5. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398 [TBL] [Abstract][Full Text] [Related]
6. Boron biodistribution study in colorectal liver metastases patients in Argentina. Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931 [TBL] [Abstract][Full Text] [Related]
7. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose. Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888 [TBL] [Abstract][Full Text] [Related]
9. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT). Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698 [TBL] [Abstract][Full Text] [Related]
10. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration. Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814 [TBL] [Abstract][Full Text] [Related]
11. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model. Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595 [TBL] [Abstract][Full Text] [Related]
12. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189 [TBL] [Abstract][Full Text] [Related]
13. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721 [TBL] [Abstract][Full Text] [Related]
14. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy. Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522 [TBL] [Abstract][Full Text] [Related]
15. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008). H-Stenstam B Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284 [No Abstract] [Full Text] [Related]
16. Effect of L-10B-p-boronophenylalanine-fructose and the boron neutron capture reaction on mouse brain dopaminergic neurons. Setiawan Y; Halliday GM; Harding AJ; Moore DE; Allen BJ Cancer Res; 1995 Feb; 55(4):874-7. PubMed ID: 7850802 [TBL] [Abstract][Full Text] [Related]
17. Prediction of boron concentrations in blood from patients on boron neutron capture therapy. Shibata Y; Matsumura A; Yamamoto T; Akutsu H; Yasuda S; Nakai K; Nose T; Yamamoto K; Kumada H; Hori N; Ohtake S Anticancer Res; 2003; 23(6D):5231-5. PubMed ID: 14981995 [TBL] [Abstract][Full Text] [Related]